Name: Serina Therapeutics, Inc. (SER) Financial Statements
Creator: FinSpry

Serina Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Serina Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2019
Revenue & Gross Profit
Revenue	0.06	3.15	0.59	3.46	1.73
Cost of Revenue	7.48	2.39	1.57	3.80	0.24
Gross Profit	-7.42	0.77	-0.98	-0.33	1.48
Operating Expenses
Research & Development	7.48	2.39	1.57	3.80	5.90
Selling, General & Administrative	8.15	3.89	1.29	1.30	8.14
Operating Expenses	8.15	6.28	2.86	5.10	14.04
Operating Income	-15.57	-3.13	-2.27	-1.63	-12.56
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.01	0.00
Interest Expense	-0.53	0.56	0.02	0.00	0.00
Other Income/Expense	13.38	8.96	-0.40	0.36	-0.29
Income
Income Before Tax	-11.21	5.27	-2.68	-1.26	-12.24
Income Tax Expense	0.00	0.00	0.00	0.00	0.15
Net Income	-11.14	5.27	-2.68	-1.26	-12.15
Net Income - Continuous Operations	-11.14	5.27	-2.68	-1.26	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-15.38	5.92	-2.60	-1.23	-11.23
EBIT	-15.57	5.83	-2.67	-1.26	-12.24
Depreciation & Amortization	0.19	0.09	0.06	0.03	-0.39
Earnings Per Share
Basic EPS	-2.00	1.00	-1.00	-1.00	-
Diluted EPS	-2.00	1.00	-1.00	-1.00	-
Basic Shares Outstanding	7.36	8.41	2.18	2.18	37.27
Diluted Shares Outstanding	7.36	8.41	7.55	7.55	37.27